NEW YORK, April 13, 2017 /PRNewswire/ --
Pre-market, Stock-Callers.com presents for evaluation Baxter InternationalInc. (NYSE: BAX), DENTSPLY SIRONA Inc. (NASDAQ: XRAY), Skyline Medical Inc. (NASDAQ: SKLN), and Hill-Rom Holdings Inc. (NYSE: HRC). According to an IBISWorld report, changing demographics, healthcare reform, and product innovation will shape the Medical
Deerfield, Illinois headquartered Baxter International Inc.'s shares rose 1.06%, finishing Wednesday's trading session at $53.53. A total volume of 3.74 million shares was traded, which was higher than their three months average volume of 2.80 million shares. In the last month and the previous three months, the stock has advanced 3.14% and 14.21%, respectively. Additionally, the Company's shares have gained 21.04% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 5.44% and 12.90%, respectively. Moreover, shares of Baxter International, which provides a portfolio of renal and hospital products, have a Relative Strength Index (RSI) of 74.79.
On April 03rd, 2017, Baxter International announced that it will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 02nd, 2017, at 9:00 a.m. CT. The live webcast of the presentation, along with the accompanying slides, can be accessed on the Company's website.
On April 04th, 2017, research firm Leerink Partners upgraded the Company's stock rating from 'Market Perform' to 'Outperform'. Free research report on BAX is available at:
On Wednesday, shares in York, Pennsylvania headquartered DENTSPLY SIRONA Inc. recorded a trading volume of 936,692 shares, and ended the session 1.10% lower at $61.99. The stock has gained 7.68% over the previous three months and 7.53% on an YTD basis. The Company's shares are trading 0.71% above their 50-day moving average and 3.02% above their 200-day moving average. Furthermore, shares of DENTSPLY SIRONA, which designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide, have an RSI of 49.02. The complimentary research report on XRAY can be downloaded at: http://stock-callers.com/registration/?symbol=XRAY
Shares in Eagan, Minnesota-based Skyline Medical Inc. closed at $2.25, rising 1.81% from the last trading session. The stock recorded a trading volume of 326,944 shares. The Company's shares have gained 7.66% in the last one month. The stock is trading 5.10% above its 50-day moving average. Additionally, shares of Skyline Medical, which manufactures environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care in the US, have an RSI of 56.19.
On March 15th, 2017, Skyline Medical reported financial results for the 3 and 12 months ended December 31st, 2016, and provided a business update. For Q4 2016, revenue was $139,563; gross profit was $107,074; and net loss available to common shareholders was $732,772. For the 12-month ended December 31st, 2016, revenue was $456,000; gross profit was $274,875; and net loss available to common shareholders was $6,526,014.Visit us today and access our complete research report on SKLN at:
Chicago, Illinois headquartered Hill-Rom Holdings Inc.'s stock ended 0.94% lower at $70.41 with a total trading volume of 257,155 shares. The Company's shares have advanced 4.12% in the last one month, 20.47% over the previous three months, and 25.75% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 6.13% and 19.75%, respectively. Furthermore, shares of Hill-Rom, which operates as a medical technology company worldwide, have an RSI of 60.71.
On March 20th, 2017, Hill-Rom announced that it will host its Q2 FY17 earnings conference call and webcast on Friday, April 28th, 2017, beginning at 8:30 a.m. ET. A simultaneous webcast of the call will be accessible via the Company's website. Get free access to your research report on HRC at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
This is a branch of telemedicine that delivers eye care via a digital medical equipment and ...
Inborn errors of metabolism are genetic disorders that hamper the body''s metabolism resulting in ...
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...View All